• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基因转移至脑过程中对腺病毒载体的免疫反应。

Immune responses to adenoviral vectors during gene transfer in the brain.

作者信息

Kajiwara K, Byrnes A P, Charlton H M, Wood M J, Wood K J

机构信息

Nuffield Department of Surgery, University of Oxford, Johm Radcliffe Hospital, UK.

出版信息

Hum Gene Ther. 1997 Feb 10;8(3):253-65. doi: 10.1089/hum.1997.8.3-253.

DOI:10.1089/hum.1997.8.3-253
PMID:9048192
Abstract

We have investigated the immune response to E1-deleted adenovirus vectors encoding the lacZ gene introduced into the brains of adult mice. Injection of these nonreplicating vectors caused a marked inflammatory response in the brain as assessed by immunocytochemistry and flow cytometry of leukocytes. Infiltrating leukocytes were detectable within 2 days of injection and reached a maximum by 9 days. Thereafter, the number of infiltrating cells decreased, but a small number persisted in the brain until day 60. Between 2 and 4 days after injection, the percentage of CD8+ cells detectable increased whereas the percentage of CD4+ cells present in the infiltrating population did not significantly increase until day 6, peaking on day 15. Activated CD25+ T cells were detectable between days 6 and 15. beta-Galactosidase (beta-Gal), the product of the lacZ gene encoded by the vector, was also detected, both at the injection site in the striatum and also in the substantia nigra. Expression peaked between 4 and 6 days but a small number of beta-Gal+ cells was still seen at 60 days after injection. This study demonstrates that a quantitative analysis of the immune responses caused by a nonreplicating adenovirus vector is possible in the brain. E1-deleted adenoviral vectors trigger a strong inflammatory response in the brain, but this immune response is not sufficient to eliminate completely expression of genes encoded by the adenoviral construct.

摘要

我们研究了成年小鼠脑内引入编码lacZ基因的E1缺失腺病毒载体后的免疫反应。通过白细胞免疫细胞化学和流式细胞术评估,注射这些非复制型载体可在脑内引发明显的炎症反应。注射后2天内可检测到浸润的白细胞,9天时达到峰值。此后,浸润细胞数量减少,但少量细胞在脑内持续存在至第60天。注射后2至4天,可检测到的CD8 +细胞百分比增加,而浸润群体中CD4 +细胞百分比直到第6天才显著增加,在第15天达到峰值。在第6天至15天之间可检测到活化的CD25 + T细胞。载体编码的lacZ基因产物β-半乳糖苷酶(β-Gal)在纹状体注射部位和黑质中均有检测到。表达在4至6天达到峰值,但注射后60天时仍可见少量β-Gal +细胞。本研究表明,在脑内对非复制型腺病毒载体引起的免疫反应进行定量分析是可行的。E1缺失腺病毒载体在脑内引发强烈的炎症反应,但这种免疫反应不足以完全消除腺病毒构建体编码基因的表达。

相似文献

1
Immune responses to adenoviral vectors during gene transfer in the brain.基因转移至脑过程中对腺病毒载体的免疫反应。
Hum Gene Ther. 1997 Feb 10;8(3):253-65. doi: 10.1089/hum.1997.8.3-253.
2
Humoral immune responses to adenovirus vectors in the brain.大脑中对腺病毒载体的体液免疫反应。
J Neuroimmunol. 2000 Feb 1;103(1):8-15. doi: 10.1016/s0165-5728(99)00220-9.
3
Variation in the immune response to adenoviral vectors in the brain: influence of mouse strain, environmental conditions and priming.大脑中对腺病毒载体免疫反应的变异:小鼠品系、环境条件及预刺激的影响
Gene Ther. 1999 Apr;6(4):471-81. doi: 10.1038/sj.gt.3300851.
4
Local adenovirus-mediated CTLA4-immunoglobulin expression suppresses the immune responses to adenovirus vectors in the brain.局部腺病毒介导的CTLA4免疫球蛋白表达可抑制大脑对腺病毒载体的免疫反应。
Neuroscience. 2000;95(1):217-26. doi: 10.1016/s0306-4522(99)00402-9.
5
Liver toxicities typically induced by first-generation adenoviral vectors can be reduced by use of E1, E2b-deleted adenoviral vectors.通过使用缺失E1、E2b的腺病毒载体,可以降低第一代腺病毒载体通常引起的肝脏毒性。
Hum Gene Ther. 2003 Dec 10;14(18):1715-26. doi: 10.1089/104303403322611737.
6
FK506 immunosuppression to control the immune reactions triggered by first-generation adenovirus-mediated gene transfer.使用FK506免疫抑制来控制第一代腺病毒介导的基因转移引发的免疫反应。
Hum Gene Ther. 1995 Nov;6(11):1391-401. doi: 10.1089/hum.1995.6.11-1391.
7
Fas-mediated apoptosis is involved in the elimination of gene-transduced hepatocytes with E1/E3-deleted adenoviral vectors.Fas介导的细胞凋亡参与了利用缺失E1/E3的腺病毒载体对基因转导肝细胞的清除过程。
J Gastroenterol Hepatol. 1998 Sep;13 Suppl:S113-8.
8
Role of T cells in inflammation caused by adenovirus vectors in the brain.T细胞在腺病毒载体引起的脑部炎症中的作用。
Gene Ther. 1996 Jul;3(7):644-51.
9
Immune responses to reporter proteins and high viral dose limit duration of expression with adenoviral vectors: comparison of E2a wild type and E2a deleted vectors.对报告蛋白的免疫反应和高病毒剂量限制腺病毒载体的表达持续时间:E2a野生型和E2a缺失载体的比较。
Hum Gene Ther. 1997 Jul 1;8(10):1275-86. doi: 10.1089/hum.1997.8.10-1275.
10
Immune responses to repetitive adenovirus-mediated gene transfer and restoration of gene expression by cyclophosphamide or etoposide.对重复腺病毒介导的基因转移的免疫反应以及环磷酰胺或依托泊苷对基因表达的恢复作用。
Gynecol Oncol. 2005 Dec;99(3 Suppl 1):S177-86. doi: 10.1016/j.ygyno.2005.07.078. Epub 2005 Oct 7.

引用本文的文献

1
Evolutionary basis of a new gene- and immune-therapeutic approach for the treatment of malignant brain tumors: from mice to clinical trials for glioma patients.一种新的基因和免疫治疗方法治疗恶性脑肿瘤的进化基础:从老鼠到胶质细胞瘤患者的临床试验。
Clin Immunol. 2018 Apr;189:43-51. doi: 10.1016/j.clim.2017.07.006. Epub 2017 Jul 15.
2
The Long and Winding Road: From the High-Affinity Choline Uptake Site to Clinical Trials for Malignant Brain Tumors.漫长而曲折的道路:从高亲和力胆碱摄取位点到恶性脑肿瘤的临床试验
Adv Pharmacol. 2016;76:147-73. doi: 10.1016/bs.apha.2016.03.002. Epub 2016 Apr 23.
3
Gene transfer into rat brain using adenoviral vectors.
使用腺病毒载体将基因导入大鼠脑内。
Curr Protoc Neurosci. 2010 Jan;Chapter 4:Unit 4.24. doi: 10.1002/0471142301.ns0424s50.
4
Immunological thresholds in neurological gene therapy: highly efficient elimination of transduced cells might be related to the specific formation of immunological synapses between T cells and virus-infected brain cells.神经基因治疗中的免疫阈值:转导细胞的高效清除可能与T细胞和病毒感染的脑细胞之间免疫突触的特异性形成有关。
Neuron Glia Biol. 2006 Nov;2(4):309-22. doi: 10.1017/S1740925X07000579.
5
One-year expression from high-capacity adenoviral vectors in the brains of animals with pre-existing anti-adenoviral immunity: clinical implications.高容量腺病毒载体在已有抗腺病毒免疫的动物大脑中的一年期表达:临床意义
Mol Ther. 2007 Dec;15(12):2154-63. doi: 10.1038/sj.mt.6300305. Epub 2007 Sep 25.
6
Gene therapy with iNOS provides long-term protection against myocardial infarction without adverse functional consequences.采用诱导型一氧化氮合酶进行基因治疗可对心肌梗死提供长期保护,且无不良功能影响。
Am J Physiol Heart Circ Physiol. 2006 Feb;290(2):H584-9. doi: 10.1152/ajpheart.00855.2005. Epub 2005 Sep 19.
7
Treatment of Parkinson's disease : what's on the horizon?帕金森病的治疗:未来有何进展?
CNS Drugs. 2005;19(9):723-43. doi: 10.2165/00023210-200519090-00001.
8
Circulating anti-wild-type adeno-associated virus type 2 (AAV2) antibodies inhibit recombinant AAV2 (rAAV2)-mediated, but not rAAV5-mediated, gene transfer in the brain.循环抗野生型2型腺相关病毒(AAV2)抗体可抑制重组AAV2(rAAV2)介导的脑部基因转移,但不抑制rAAV5介导的脑部基因转移。
J Virol. 2004 Jun;78(12):6344-59. doi: 10.1128/JVI.78.12.6344-6359.2004.
9
Nonneurotropic adenovirus: a vector for gene transfer to the brain and gene therapy of neurological disorders.非嗜神经性腺病毒:一种用于向脑部进行基因转移及神经系统疾病基因治疗的载体。
Int Rev Neurobiol. 2003;55:3-64. doi: 10.1016/s0074-7742(03)01001-8.
10
Adenovirus-mediated gene transfer of B7.1 induces immunological anti-tumor effects in a murine brain tumor.腺病毒介导的B7.1基因转移在小鼠脑肿瘤中诱导免疫抗肿瘤效应。
J Neurooncol. 2002 Oct;60(1):13-23. doi: 10.1023/a:1020260822669.